menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales

11 1
05.02.2025
"We expect another year of profitable growth in 2025, and have further improved our long-term outlook," said CEO Walmsley.

© Fortune